| Date Filed | Type | Description |
| 06/10/2020 |
4
| Gionco David (Chief Accounting Officer) has filed a Form 4 on STEMLINE THERAPEUTICS INC|
Txns:
| Granted 45,000 shares
@ $0
Unknown transaction of 327,878 shares
@ $0
Disposed/sold 45,102 options to buy
@ $4.12, valued at
$185.8k
|
|
| 04/03/2020 |
4
| Gionco David (Chief Accounting Officer) has filed a Form 4 on STEMLINE THERAPEUTICS INC|
Txns:
| Sold 11,524 shares
@ $4.79, valued at
$55.2k
|
|
| 03/20/2020 |
4
| Gionco David (Chief Accounting Officer) has filed a Form 4 on STEMLINE THERAPEUTICS INC|
Txns:
| Sold 2,849 shares
@ $3.88, valued at
$11.1k
|
|
| 03/13/2020 |
4
| Gionco David (Chief Accounting Officer) has filed a Form 4 on STEMLINE THERAPEUTICS INC|
Txns:
| Sold 5,011 shares
@ $5.08, valued at
$25.5k
Sold 8,846 shares
@ $4.92, valued at
$43.5k
|
|
| 02/28/2020 |
4
| Gionco David (Chief Accounting Officer) has filed a Form 4 on STEMLINE THERAPEUTICS INC|
Txns:
| Sold 9,147 shares
@ $6.43, valued at
$58.8k
|
|
| 02/14/2020 |
4
| Gionco David (Chief Accounting Officer) has filed a Form 4 on STEMLINE THERAPEUTICS INC|
Txns:
| Granted 107,317 shares
@ $0 |
|
| 01/03/2020 |
4
| Gionco David (Chief Accounting Officer) has filed a Form 4 on STEMLINE THERAPEUTICS INC|
Txns:
| Sold 421 shares
@ $10.58, valued at
$4.5k
Sold 2,388 shares
@ $10.97, valued at
$26.2k
Sold 1,511 shares
@ $10.75, valued at
$16.2k
Sold 197 shares
@ $10.48, valued at
$2.1k
|
|
| 05/17/2019 |
4
| Gionco David (Chief Accounting Officer) has filed a Form 4 on STEMLINE THERAPEUTICS INC|
Txns:
| Granted 15,000 shares
@ $0 |
|
| 03/15/2019 |
4
| Gionco David (Chief Accounting Officer) has filed a Form 4 on STEMLINE THERAPEUTICS INC|
Txns:
| Sold 13,492 shares
@ $11.11, valued at
$149.9k
Sold 530 shares
@ $11.05, valued at
$5.9k
|
|
| 03/08/2019 |
4
| Gionco David (Chief Accounting Officer) has filed a Form 4 on STEMLINE THERAPEUTICS INC|
Txns:
| Sold 1,381 shares
@ $11.32, valued at
$15.6k
|
|
| 02/27/2019 |
4
| Gionco David (Chief Accounting Officer) has filed a Form 4 on STEMLINE THERAPEUTICS INC|
Txns:
| Sold 8,563 shares
@ $12.03, valued at
$103k
|
|
| 02/08/2019 |
4
| Gionco David (Chief Accounting Officer) has filed a Form 4 on STEMLINE THERAPEUTICS INC|
Txns:
| Granted 15,000 shares
@ $0
Granted 69,550 shares
@ $0
Granted 9,009 shares
@ $0 |
|
| 03/14/2018 |
4
| Gionco David (Chief Accounting Officer) has filed a Form 4 on STEMLINE THERAPEUTICS INC|
Txns:
| Sold 7,658 shares
@ $17.2, valued at
$131.7k
Sold 1,525 shares
@ $18.28, valued at
$27.9k
|
|
| 03/09/2018 |
4
| Gionco David (Chief Accounting Officer) has filed a Form 4 on STEMLINE THERAPEUTICS INC|
Txns:
| Sold 1,413 shares
@ $16.56, valued at
$23.4k
Granted 37,592 shares
@ $0 |
|
| 02/28/2018 |
4
| Gionco David (Chief Accounting Officer) has filed a Form 4 on STEMLINE THERAPEUTICS INC|
Txns:
| Sold 4,400 shares
@ $17.61, valued at
$77.5k
Sold 4,584 shares
@ $17.26, valued at
$79.1k
|
|
| 01/19/2018 |
4
| Gionco David (Chief Accounting Officer) has filed a Form 4 on STEMLINE THERAPEUTICS INC|
Txns:
| Sold 4,250 shares
@ $13.43, valued at
$57.1k
|
|
| 03/09/2017 |
4
| Gionco David (Chief Accounting Officer) has filed a Form 4 on STEMLINE THERAPEUTICS INC|
Txns:
| Sold 1,116 shares
@ $8.13, valued at
$9.1k
Granted 70,299 shares
@ $0 |
|
| 03/01/2017 |
4
| Gionco David (Chief Accounting Officer) has filed a Form 4 on STEMLINE THERAPEUTICS INC|
Txns:
| Sold 3,500 shares
@ $6.97, valued at
$24.4k
Sold 2,986 shares
@ $7.01, valued at
$20.9k
|
|
| 01/24/2017 |
4
| Gionco David (Chief Accounting Officer) has filed a Form 4 on STEMLINE THERAPEUTICS INC|
Txns:
| Sold 3,593 shares
@ $11.46, valued at
$41.2k
|
|
| 03/10/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/26/2016 |
4
| Gionco David (Chief Accounting Officer) has filed a Form 4 on STEMLINE THERAPEUTICS INC |
| 10/17/2013 |
4
| Gionco David (Chief Accounting Officer) has filed a Form 4 on SAVIENT PHARMACEUTICALS INC|
Txns:
| Sold 5,476 shares
@ $0.0802, valued at
$439.2
Sold 8,500 shares
@ $0.0803, valued at
$682.6
Sold 3,000 shares
@ $0.0804, valued at
$241.2
Sold 20,900 shares
@ $0.0805, valued at
$1.7k
Sold 10,000 shares
@ $0.081, valued at
$810 |
|
| 03/08/2013 |
4
| Gionco David (Group VP & Chief Acct. Officer) has filed a Form 4 on SAVIENT PHARMACEUTICALS INC|
Txns:
| Sold 1,560 shares
@ $0.93, valued at
$1.5k
|
|
| 03/07/2013 |
4
| Gionco David (Group VP & Chief Acct. Officer) has filed a Form 4 on SAVIENT PHARMACEUTICALS INC|
Txns:
| Granted 29,000 shares
@ $0 |
|
| 07/25/2012 |
3
| Gionco David (Group VP & Chief Acct Officer) has filed a Form 3 on SAVIENT PHARMACEUTICALS INC |
| 01/27/2011 |
4
| Gionco David (Group VP & CFO) has filed a Form 4 on SAVIENT PHARMACEUTICALS INC|
Txns:
| Granted 144 shares
@ $11.4495, valued at
$1.6k
Granted 71 shares
@ $10.234, valued at
$726.6
Granted 60 shares
@ $11.951, valued at
$717.1
Granted 73 shares
@ $10.03, valued at
$732.2
Sold 2,032 shares
@ $10, valued at
$20.3k
|
|
| 12/30/2010 |
4
| Gionco David (Group VP & CFO) has filed a Form 4 on SAVIENT PHARMACEUTICALS INC|
Txns:
| Sold 1,536 shares
@ $11.8702, valued at
$18.2k
|
|
| 09/20/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/17/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/11/2010 |
4
| Gionco David (Group VP & CFO) has filed a Form 4 on SAVIENT PHARMACEUTICALS INC|
Txns:
| Sold 2,037 shares
@ $12.7652, valued at
$26k
|
|
| 12/22/2009 |
4
| Gionco David (VP, CFO) has filed a Form 4 on SAVIENT PHARMACEUTICALS INC|
Txns:
| Granted 61 shares
@ $11.3475, valued at
$692.2
Sold 1,511 shares
@ $12.946, valued at
$19.6k
|
|
| 09/15/2009 |
4
| Gionco David (Group VP, CFO) has filed a Form 4 on SAVIENT PHARMACEUTICALS INC |
| 02/25/2009 |
3/A
| Gionco David (VP, CFO) has filed a Form 3/A on SAVIENT PHARMACEUTICALS INC |
| 02/24/2009 |
3
| Gionco David (VP, CFO) has filed a Form 3 on SAVIENT PHARMACEUTICALS INC |